These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31939437)

  • 1. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
    Song Z; Ye J; Wang Y; Li Y; Wang W
    J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
    Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
    Eur J Surg Oncol; 2024 Jul; 50(7):108429. PubMed ID: 38788357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-guided radioactive iodine-125 seed implantation for liver malignancies in challenging locations.
    Li L; Tian S; Han X; Tian J; Zhang C
    J Cancer Res Ther; 2024 Aug; 20(4):1165-1172. PubMed ID: 39206978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of computed tomography-guided
    He C; Liu Y; Li Y; Yang L; Li YT; Li SL; Huang XQ
    J Cancer Res Ther; 2018; 14(4):754-759. PubMed ID: 29970648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
    Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma.
    Zhang FJ; Li CX; Zhang L; Wu PH; Jiao DC; Duan GF
    Cancer Biol Ther; 2009 Apr; 8(7):585-90. PubMed ID: 19276683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
    Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
    Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
    Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.
    Ümütlü MR; Öcal O; Puhr-Westerheide D; Fabritius MP; Wildgruber M; Deniz S; Corradini S; Rottler M; Walter F; Rogowski P; Seidensticker R; Philipp AB; Rössler D; Ricke J; Seidensticker M
    Dig Dis; 2024; 42(5):461-472. PubMed ID: 38781948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
    Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
    Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.
    Qiu Z; Yu C; Qiu X; Li Q; Li J; Chen Z; Chang S; Zhang S; Fan G; Wang S
    Acad Radiol; 2023 Sep; 30 Suppl 1():S53-S60. PubMed ID: 36882354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
    Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
    J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
    Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
    Gordon AC; Gabr A; Riaz A; Uddin OM; Abouchaleh N; Ali R; Kallini J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1557-1565. PubMed ID: 29948005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
    Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
    Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of
    Xiang Z; Bai M; Li G; Zou B; Zhong Z; Gao F; Wu C; Huang M; Zhang F
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1907-1916. PubMed ID: 31161374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.